The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Eli Lilly Invests 3 Billion to Expand Wisconsin Plant Amid Drug Demand Surge
Eli Lilly is investing $3 billion to expand its manufacturing plant in Pleasant Prairie, Wisconsin, to meet the rising demand for its weight-loss drug Zepbound and diabetes treatments. This marks the company's largest U.S. manufacturing investment outside Indiana, with plans to create 750 new jobs and begin production by late 2025. Lilly's total investment in the site will reach $4 billion, reflecting its commitment to increasing capacity amid ongoing drug shortages.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.